Paper365072
Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
van Rossum J and 4 others. Ann Neurol, 1977. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Papers, record 365072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/365072
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Tranexamic Acid | Major topic |
| Aged | |
| Cerebral Angiography | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Humans | |
| Intracranial Aneurysm | |
| Middle Aged | |
| Prognosis | |
| Recurrence |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42095754 | European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42095754 | PubMed |
| 40599738 | Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis. | Front Neurol | 2025 | https://conductscience.org/library/papers/40599738 | PubMed |
| 40316838 | Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40316838 | PubMed |
| 37228855 | The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. | Future Sci OA | 2023 | https://conductscience.org/library/papers/37228855 | PubMed |
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 35140671 | Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. | Front Neurol | 2021 | https://conductscience.org/library/papers/35140671 | PubMed |
| 35083272 | Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Front Surg | 2021 | https://conductscience.org/library/papers/35083272 | PubMed |
| 34677620 | Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/34677620 | PubMed |
| 34315966 | Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34315966 | PubMed |
| 23990381 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23990381 | PubMed |
| 21761274 | Rebleeding after aneurysmal subarachnoid hemorrhage. | Neurocrit Care | 2011 | https://conductscience.org/library/papers/21761274 | PubMed |
| 18386187 | Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. | Neurocrit Care | 2008 | https://conductscience.org/library/papers/18386187 | PubMed |
| 10400410 | Tranexamic acid: a review of its use in surgery and other indications. | Drugs | 1999 | https://conductscience.org/library/papers/10400410 | PubMed |
| 9854979 | Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage. | J Neurol Neurosurg Psychiatry | 1998 | https://conductscience.org/library/papers/9854979 | PubMed |
| 7435290 | Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435290 | PubMed |
| 7376944 | Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7376944 | PubMed |
| 7282453 | Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage. | Acta Neurochir (Wien) | 1981 | https://conductscience.org/library/papers/7282453 | PubMed |
| 7229645 | Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7229645 | PubMed |
| 7131009 | Ruptured intracranial aneurysms: has the incidence of early rebleeding been over-estimated? | J Neurol Neurosurg Psychiatry | 1982 | https://conductscience.org/library/papers/7131009 | PubMed |
| 7048863 | Antifibrinolytic treatment in subarachnoid haemorrhage: present state. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/7048863 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/365072
GET https://conductscience.org/api/papers/v1/365072/cited_by?page=2